Humanigen Inc (HGENQ)

[cowtown jay]

"Biotech giant Pfizer expects to generate $33.5 billion in Covid-19 vaccine sales in 2021, up from previous estimates of $26 billion, according to its second quarter earnings reports. These projections are based on the 2.1 billion doses of the Pfizer/BioNTech vaccine which the company expects to manufacture and deliver by the end of the year...

The company generated $9.2 billion in vaccine sales in the second quarter of 2021 alone...

In June 2021, Pfizer began a phase 2 study to evaluate its vaccine safety in children in the age group of 6 months to 11 years old...

Covid booster shot...given at least 6 months after the second dose..."

https://www.forbes.com/sites/aayushipratap/2021/07/28/pfizer-expects-335-billion-in-vaccine-revenue-in-2021/?sh=5714681d217d

That's just one of the three domestic suppliers approved as of now, with more manufacturers entering the market, plus the international vaccine manufacturers. Ten trillion dollars seems like a fairly accurate revenue guess.

That doesn't account for grant revenue, either. Moderna reported, "... grant revenue of $101 million and $291 million for the three and six months ended June 30, 2021, respectively, were primarily driven by increases in revenue from BARDA related to the Company's COVID-19 vaccine development."

https://investors.modernatx.com/news-releases/news-release-details/moderna-reports-second-quarter-fiscal-year-2021-financial

As I said in my post yesterday, if lenz could be administered in an ER setting based on elevated CRP levels, "...we could be looking at 100M+ treatments, and trillions in revenue."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165695386&txt2find=trillion

In the next 12 months, we could be fairly close to starting a revenue stream from other indications also, such as CMML, GvHD, and CAR-T, as well, where lenz is used as a prophylactic.

There's a lot of money on the line. And we are a small, independent, microcap biotech...until we can start a revenue stream. I have more hope in our chances of UK approval, than I do in FDA approval. But I keep hoping that the FDA will approve our EUA, even if that takes oversight review.